Establish Stability Protocols for Combination Products – Tongue Depressors, Catheters, and Drug-eluting Stents

Speaker Jim Watson, Vice President, ProjectFarma, a PerkinElmer Company

To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.

You must log in to view this content.

Speaker Jim Watson, Vice President, ProjectFarma, a PerkinElmer Company
To access this post, you must purchase MEMBER PLUS + or MEMBER PLUS 6M FREE.

Recent Items

More resources

31 E Kings Highway
2nd Floor Haddonfield, NJ 08033

  • Email: info@kenx.org
  • Phone: 858 649 3251
  • Email: info@kenx.org
  • Phone: 858 649 3251
Facebook-f Linkedin-in